Literature DB >> 3019230

Reduced phospholipase D activity in brain tissue samples from Alzheimer's disease patients.

J N Kanfer, H Hattori, D Orihel.   

Abstract

Biochemical examinations of brain tissue samples obtained from patients with Alzheimer's disease have revealed a decreased quantity of the neurotransmitter acetylcholine and reduced activity of choline acetyltransferase (ChAT), the enzyme responsible for acetylcholine formation. It has been suggested that the choline moiety of lecithin, a substitute ubiquitously present in membranes of mammalian cells, could be mobilized for acetylcholine formation. The activity of phospholipase D, an enzyme which releases choline directly from lecithin, was measured in homogenates of Alzheimer brain tissue and found to be reduced by 63%. ChAT activity was reduced by 58% and 5'-nucleotidase activity was reduced by 27% in these homogenates.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019230     DOI: 10.1002/ana.410200214

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

Review 1.  Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids.

Authors:  A A Farooqui; L Liss; L A Horrocks
Journal:  Metab Brain Dis       Date:  1988-03       Impact factor: 3.584

2.  Novel susceptibility loci for Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Future Neurol       Date:  2015-12

3.  The influence of acute ethanol ingestion on phospholipase D activity in rat pancreas. An in vitro and in vivo study.

Authors:  G Rydzewska; G Jurkowska; A Gabryelewicz
Journal:  Int J Pancreatol       Date:  1996-08

Review 4.  Phospholipase D in brain function and Alzheimer's disease.

Authors:  Tiago Gil Oliveira; Gilbert Di Paolo
Journal:  Biochim Biophys Acta       Date:  2010-04-23

5.  Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits.

Authors:  Tiago Gil Oliveira; Robin B Chan; Huasong Tian; Mikael Laredo; Guanghou Shui; Agnieszka Staniszewski; Hong Zhang; Lili Wang; Tae-Wan Kim; Karen E Duff; Markus R Wenk; Ottavio Arancio; Gilbert Di Paolo
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

6.  Oxidative inactivation of brain ecto-5'-nucleotidase by thiols/Fe2+ system.

Authors:  X W Liu; D E Sok
Journal:  Neurochem Res       Date:  2000-11       Impact factor: 3.996

7.  Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation.

Authors:  Dongming Cai; William J Netzer; Minghao Zhong; Yixin Lin; Guangwei Du; Michael Frohman; David A Foster; Sangram S Sisodia; Huaxi Xu; Fred S Gorelick; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-31       Impact factor: 11.205

8.  Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons.

Authors:  Dongming Cai; Minghao Zhong; Runsheng Wang; William J Netzer; Dennis Shields; Hui Zheng; Sangram S Sisodia; David A Foster; Fred S Gorelick; Huaxi Xu; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-31       Impact factor: 11.205

9.  Developmental changes and regional distribution of phospholipase D and base exchange enzyme activities in rat brain.

Authors:  M Kobayashi; D G McCartney; J N Kanfer
Journal:  Neurochem Res       Date:  1988-08       Impact factor: 3.996

10.  Alterations of selected enzymes of phospholipid metabolism in Alzheimer's disease brain tissue as compared to non-Alzheimer's demented controls.

Authors:  J N Kanfer; J W Pettegrew; J Moossy; D G McCartney
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.